Trials / Completed
CompletedNCT01771081
Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy
POLARIS: A Non-interventional Study in Patients With Diabetic Macular Edema (DME) With Central Involvement to Assess the Effectiveness of Existing Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment Regimens
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 911 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
POLARIS : A non-interventional study in patients with diabetic macular edema (DME) with central involvement to assess the effectiveness of existing anti-vascular endothelial growth factor (anti-VEGF) treatment regimens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ranibizumab (or other DME treatment) | Patients with DME having started treatment with an approved anti-VEGF therapy at or after 01 October 2012 and then continuing with this or any kind or no treatment |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2015-01-01
- Completion
- 2015-04-01
- First posted
- 2013-01-18
- Last updated
- 2015-10-28
Locations
8 sites across 8 countries: France, Germany, Greece, Portugal, Russia, Slovakia, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT01771081. Inclusion in this directory is not an endorsement.